Medication Management at ADHD Philadelphia
Medication management is one component of a comprehensive ADHD treatment plan.
For adults in Pennsylvania and Delaware, we provide:
• Evidence-based stimulant prescribing when clinically appropriate
• Non-stimulant medication options
• Structured 30-day follow-up monitoring
• Executive function support integration
• Ongoing reassessment of treatment effectiveness
Our goal is not just symptom reduction — but safe, sustainable, and responsible long-term care.
Stimulant Treatment Policy & Monitoring Standards
🏛 Stimulant Treatment Policy & Monitoring Standards
Safe, Structured ADHD Care in Pennsylvania and Delaware
At ADHD Philadelphia, we provide evidence-based treatment for adults with Attention-Deficit/Hyperactivity Disorder (ADHD).
Stimulant medications can be highly effective when prescribed appropriately. They can improve focus, task initiation, and overall executive functioning. However, because these medications are federally regulated controlled substances, they require thoughtful monitoring and responsible medical oversight.
Our goal is simple:
Provide effective treatment while prioritizing long-term safety, compliance, and clinical integrity.
Below is an overview of how stimulant treatment is managed in our practice.
Why Stimulant Medications Require Monitoring
Medications such as Adderall (amphetamine salts), Vyvanse (lisdexamfetamine), and methylphenidate-based treatments are classified as Schedule II controlled substances under federal law.
This classification exists because these medications:
Have clear medical benefit when properly prescribed
Carry potential for misuse or diversion
Require ongoing medical oversight
Must be prescribed in compliance with Pennsylvania and Delaware regulations
Monitoring is not about mistrust.
It is about safety, compliance, and responsible prescribing.
Our 30-Day Monitoring Model
All stimulant treatment at ADHD Philadelphia is evaluated on a structured 30-day basis.
This typically includes:
Prescriptions written in 30-day supplies
Regular review of symptom response
Assessment of side effects
Ongoing evaluation of medical necessity
Treatment adjustments when clinically indicated
This model ensures that medication remains effective, appropriate, and aligned with your treatment goals.
Prescription Drug Monitoring Program (PDMP) Review
Before issuing any stimulant prescription, we check the Prescription Drug Monitoring Program (PDMP) every time.
The PDMP is a state-regulated database used across Pennsylvania and Delaware to:
Promote patient safety
Prevent medication duplication
Identify potential drug interactions
Reduce misuse and diversion
PDMP review is a standard part of responsible stimulant prescribing in our practice.
Cardiovascular Safety & Possible EKG Requirements
Stimulants may increase heart rate and blood pressure.
Depending on your medical history, you may be asked to:
Obtain an EKG prior to starting medication
Provide clearance from a primary care provider or cardiologist
Monitor blood pressure regularly
Participate in follow-up cardiovascular assessments
Your safety always comes first.
Urine Drug Screening & Follow-Up Appointments
Because stimulant medications are controlled substances, periodic monitoring may include:
Urine drug screening
Structured follow-up visits
Occasional in-person appointments when clinically indicated
Monitoring requirements are individualized, but participation in follow-up care is part of responsible treatment.
Substance Use Policy
Stimulant prescribing in our practice requires abstinence from non-prescribed substances.
This includes:
Cannabis, marijuana, THC products (including medical marijuana)
Illicit substances
Misuse of alcohol
Unauthorized prescription medications
This policy exists to:
Reduce cardiovascular risk
Reduce psychiatric risk
Minimize medication interaction complications
Maintain compliance with professional prescribing standards
If substance use concerns arise, stimulant treatment may be paused or discontinued.
We understand this policy may not be the right fit for everyone — and we are transparent about that from the start.
Who We May Not Be the Best Fit For
We may not be the best clinical match for individuals who:
Prefer minimal monitoring
Are unwilling to participate in follow-up requirements
Wish to combine stimulant treatment with cannabis use
Seek early refills or non-structured prescribing
We specialize in structured, safety-focused ADHD care.
Alternatives to Stimulant Medication
Stimulants are not the only treatment option for ADHD.
We also discuss:
Non-stimulant medications
Executive functioning support strategies
ADHD-focused cognitive behavioral therapy
Behavioral structure systems
Sleep, exercise, and lifestyle optimization
Treatment plans are individualized based on your goals and medical history.
Our Commitment to Responsible ADHD Care in PA & DE
We are committed to:
Ethical prescribing
Evidence-based treatment
Transparent policies
Regulatory compliance
Long-term patient safety
Our goal is not just symptom improvement —
but sustainable, medically responsible ADHD management.
Ready to Begin?
If you are an adult located in Pennsylvania or Delaware seeking structured ADHD evaluation and treatment, we invite you to schedule an appointment.
👉 Book Your ADHD Evaluation Today
Telehealth appointments are available throughout PA and DE.
In-person appointments may be scheduled after the initial telehealth visit.